Study S001137

Efficacy and Safety of Mazdutide Injection for the Treatment of Overweight Patients With Compensated Cirrhosis and Clinically Significant Portal Hypertension

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07797101
Acronym: B-REACH
Study type: INTERVENTIONAL
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 50
Start: 2026-09-01
Primary completion: 2029-05-31
Lead sponsor: The Second Affiliated Hospital of Chongqing Medical University
Conditions: Cirrhosis; Portal Hypertension; Fatty Liver Disease; GLP-1
Interventions: DRUG:Mazdutide injection
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Percentage Change in Hepatic Venous Pressure Gradient (HVPG) from Baseline [Baseline (screening, Day -14 to -1) to Week 16 (End of Treatment, Day 112 ± 3 days)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.